X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER LETTERS

期刊標題檢索 CANCER LETT 最新評論: Review speed: 1.0 | Submission hit rate: 50.0 Research focus: Tumor... (2024-10-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER LETTERS]您好,您是該頁面的第 330968 位訪客。

期刊簡介
期刊名稱CANCER LETTERS CANCER LETTERS
LetPub Score
9.0
51 ratings
Rate

Reputation
9.8

Influence
8.2

Speed
9.2

期刊簡稱CANCER LETT
ISSN0304-3835
E-ISSN1872-7980
h-index161
CiteScore
CiteScoreSJRSNIPCiteScore Rank
17.702.5951.470
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q126 / 404
Category: Medicine
Subcategory: Cancer Research
Q119 / 230

自引率 (2023-2024)6.60%自引率趨勢
掲載範囲
CANCER LETTERS is a journal providing rapid publication of full-length articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease.
官方網站https://www.journals.elsevier.com/cancer-letters
在線稿件提交https://www.editorialmanager.com/CANLET
開放訪問No
出版商Elsevier Ireland Ltd
主題領域医学
出版國/地區NETHERLANDS
發行頻率隔週刊行
創刊年1975
每年文章數279每年文章數趨勢
黃金OA百分比28.32%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ133/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0304-3835%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 2.7 month(s)
來自Elsevier的數據: Average 3.3 Week(s)
競爭力 *來自作者的數據: About 52.27%
在線文章發布時間來自Elsevier的數據: Average 8.3 Week(s)
參考鏈接
相關期刊 【CANCER LETTERS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER RESEARCH312133
    BMC CANCER245502
    Asian Pacific Journal of Cancer Prevention219203
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191629
    CLINICAL CANCER RESEARCH181666
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176414
    ONCOLOGY REPORTS175031
    CA-A CANCER JOURNAL FOR CLINICIANS163632
    CANCER148385
  •  

    CANCER LETTERS CANCER LETTERS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/58)
  [CANCER LETTERS] 的評論撰寫評論
作者: 风啸俊衡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 13:01:24 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Research focus: Tumor; Drug resistance mechanism
Experience sharing: 
05.22 Submitted to Journal
05.22 With editor 
05.24 Under review 
06.14 Required reviews completed 
06.18 Major revision

The first reviewer gave a month for the first review. The first reviewer provided more than 20 detailed opinions, all of which were easily resolved. The second reviewer had one suggestion, requesting a change in animal model for validation. To meet the second reviewer's request, the revision time was extended by two months.
09.17 Revision Submitted to Journal
09.20 Under review 
09.27 Required reviews completed
10.01 Minor revision

The second review gave 7 days for revision. The first reviewer believed it was almost suitable for publication, but based on the revision note, provided three additional opinions, including adding text explanations and supplementary data. The second reviewer believed it was acceptable for publication.
10.07 Revision Submitted to Journal
10.08 With Editor 
10.13 Under review
10.15 Required reviews completed

The pace of the third review is clearly slower, and it is unknown when feedback will be received, causing anxiety.
(0) 讚! | 风啸俊衡

作者: 通幽阉茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 15:04:55 評論於
Connect connect connect.
(0) 讚! | 通幽阉茂

作者: 是你的庆娇呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-14 10:59:47 評論於
How are you now? Please update your status.
(0) 讚! | 是你的庆娇呀

作者: 风啸俊衡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-07 21:04:30 評論於
Submissions Being Processed. You should see your submitted articles here.
(0) 讚! | 风啸俊衡

作者: 魔都吉星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-05 10:19:01 評論於
Did you receive the email confirming the successful submission of the manuscript? I submitted it in January this year and it is still under review.
(0) 讚! | 魔都吉星

作者: 神照正阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-01 20:52:21 評論於
After I submitted, I logged into the corresponding author account and couldn't see the article I submitted. What's going on? Please help~~ Submissions Waiting for Author's Approval (0)
(0) 讚! | 神照正阳

作者: 火焰成周


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-01 20:27:40 評論於
I did not ask for the format to be changed, I sent an email to other editing experts for review, and when I checked today it had become DIP.
(0) 讚! | 火焰成周

作者: 魔都吉星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 22:31:42 評論於
Can this still be arranged in advance?
(0) 讚! | 魔都吉星

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 18:13:21 評論於
Nine months and still no results, there should have been a repair midway through.
(0) 讚! | Adelaide Lawson

作者: 魔都吉星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 13:09:36 評論於
I have been investing for 9 months... It's too difficult - - !!!
(0) 讚! | 魔都吉星

作者: 魔都吉星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 13:06:27 評論於
I have been applying for 9 months, not sure of the results. It's really hard.
(0) 讚! | 魔都吉星

作者: 魔都吉星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 10:20:49 評論於
Pass it on!
(0) 讚! | 魔都吉星

作者: 京城熙华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-19 13:48:18 評論於
Please accept!!!
(0) 讚! | 京城熙华

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 17:47:51 評論於
There is no need to be so strict, as long as the quality of the content is solid.
(0) 讚! | Adelaide Lawson

作者: 努力啊大绮云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-17 23:59:49 評論於
Have you submitted it? Did you include the method in the attachment? Does it include 3500 words including references?
(0) 讚! | 努力啊大绮云

作者: 风啸俊衡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-17 19:48:22 評論於
Not strict, I submitted more than 4700 including materials and methods, nothing special.
(0) 讚! | 风啸俊衡

作者: 风啸俊衡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-17 11:21:18 評論於
If the content is acceptable, there is no need to nitpick over minor details.
(0) 讚! | 风啸俊衡

作者: 星熊楚恒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 17:51:44 評論於
+1, can any experienced investors who have invested before share their thoughts?
(0) 讚! | 星熊楚恒

作者: sunshineZY


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-09 21:21:59 評論於
Submitted on July 2, 2024, sent for external review on July 17, still under external review until September 9, the first review has been ongoing for 54 days, which is much longer than the 29-day review period stated on the official website. I am anxious to graduate. Has anyone encountered this situation before? Should I patiently wait or contact the journal by writing a letter? I hope to receive the first review comments as soon as possible and publish smoothly!
(0) 讚! | sunshineZY

作者: sunshineZY


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-09 17:47:04 評論於
It has been almost two months since the first review, and there is still no response. Is this speed normal? The status shows that 9 reviewers have been contacted, 3 have accepted the review, but only one has provided feedback. I am debating whether to write a letter to inquire, as I am anxious to graduate and feeling very stressed.
(0) 讚! | sunshineZY

作者: sunshineZY


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-09 17:32:09 評論於
How long did it take for your first review? My external review has been almost two months now, and I am anxious to graduate. It is making me feel very stressed.
(0) 讚! | sunshineZY

作者: 星熊楚恒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-07 19:54:42 評論於
Is the word count limit of 3500 strict for the submissions? Can the materials and methods section be included as an attachment? Thank you!
(0) 讚! | 星熊楚恒

作者: 般若华楚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-02 09:12:04 評論於
Update to gain reputation, fix it and get direct approval. Today UR, hoping the reviewer suggests acceptance.
(0) 讚! | 般若华楚

作者: 凡绿子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-01 15:59:53 評論於
Update, 2024.08.14 Revision Complete
2024.08.14 With editor
2024.08.15 Under Review
2024.08.30 Required review complete
2024.08.31 Decision in Process
2024.09.02 Accepted
(0) 讚! | 凡绿子

作者: 京城士航


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-30 17:51:29 評論於
Do all magazines require a second review? My situation is a bit special, and I would like to extend the process as much as possible ?.
(0) 讚! | 京城士航

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/58)

開始撰寫 [CANCER LETTERS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*